Monocyte chemoattractant protein-1 polymorphism interaction with spirulina immunomodulatory effects in healthy Korean elderly: A 16-week, double-blind randomized clinical trial

키워드

참고문헌 (61)

1. Muller WA, "Getting leukocytes to the site of inflammation", Vet Pathol, 50, pp.7~22 (2013)
2. Xu L, "MCP-1induces proliferation and migration of vascular smooth muscle cells", FASEB J, 10, pp.A1932~ (1996)
3. Luster AD, "Chemokines--chemotactic cytokines that mediate inflammation", N Engl J Med, 338, pp.436~445 (1998)
4. Rossi D, "The biology of chemokines and their receptors", Annu Rev Immunol, 18, pp.217~242 (2000)
5. Salcedo R, "Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression", Blood, 96, pp.34~40 (2000)
6. Inadera H, "Increase in circulating levels of monocyte chemoattractant protein-1 with aging", J Interferon Cytokine Res, 19, pp.1179~1182 (1999)
7. Rovin BH, "A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression", Biochem Biophys Res Commun, 259, pp.344~348 (1999)
8. Martin ES, "The -2518 A", G polymorphism in the monocyte chemoattractant protein 1 gene (MCP-1) is associated with an increased risk of rheumatoid arthritis in Argentine patients, 2016, pp.35, 3057~3061
9. Wang W, "Association of monocyte chemoattractant protein-1 gene 2518A", G polymorphism with diabetic retinopathy in type 2 diabetes mellitus: a meta-analysis, 2016, pp.120, 40~46
10. Niu J, "Role of MCP-1 in cardiovascular disease:molecular mechanisms and clinical implications", Clin Sci (Lond), 117, pp.95~109 (2009)
11. Mansego ML, "The nutrigenetic influence of the interaction between dietary vitamin E and TXN and COMT gene polymorphisms on waist circumference: a case control study", J Transl Med, 13, pp.286~ (2015)
12. Pase CS, "Olive oil-enriched diet reduces brain oxidative damages and ameliorates neurotrophic factor gene expression in different life stages of rats", J Nutr Biochem, 26, pp.1200~1207 (2015)
13. Pietropaolo S, "Dietary supplementation of omega-3 fatty acids rescues fragile X phenotypes in Fmr1-Ko mice", Psychoneuroendocrinology, 49, pp.119~129 (2014)
14. Nigam A, "Fish oil for the reduction of atrial fibrillation recurrence, inflammation, and oxidative stress", J Am Coll Cardiol, 64, pp.1441~1448 (2014)
15. Yanaka A, "Dietary sulforaphane-rich broccoli sprouts reduce colonization and attenuate gastritis in Helicobacter pylori-infected mice and humans", Cancer Prev Res (Phila), 2, pp.353~360 (2009)
16. Vicari E, "Chronic bacterial prostatitis and irritable bowel syndrome: effectiveness of treatment with rifaximin followed by the probiotic VSL#3", Asian J Androl, 16, pp.735~739 (2014)
17. Ortega-Azorín C, "Associations of the FTO rs9939609 and the MC4R rs17782313 polymorphisms with type 2diabetes are modulated by diet, being higher when adherence to the Mediterranean diet pattern is low", Cardiovasc Diabetol, 11, pp.137~ (2012)
18. Serrano JC, "Vitamin D receptor BsmI polymorphism modulates soy intake and 25-hydroxyvitamin D supplementation benefits in cardiovascular disease risk factors profile", Genes Nutr, 8, pp.561~569 (2013)
19. Giacconi R, "Effect of ZIP2 Gln", Arg, Biofactors, pp.2015, 41[DOI]
20. Park S, "TRPV1 gene polymorphisms are associated with type 2 diabetes by their interaction with fat consumption in the Korean genome epidemiology study", J Nutrigenet Nutrigenomics, 9, pp.47~61 (2016)
21. Thengodkar RR, "Degradation of Chlorpyrifos by an alkaline phosphatase from the cyanobacterium Spirulina platensis", Biodegradation, 21, pp.637~644 (2010)
22. Lee JB, "Effects of structural modification of calcium spirulan, a sulfated polysaccharide from Spirulina platensis, on antiviral activity", Chem Pharm Bull (Tokyo), 49, pp.108~110 (2001)
23. Marcel AK, "The effect of Spirulina platensis versus soybean on insulin resistance in HIV-infected patients:a randomized pilot study", Nutrients, 3, pp.712~724 (2011)
24. Nkengfack G, "Effects of nutritional education and lifestyle modification on the nutritional status of HIV positive patients: results of a cluster randomized intervention over a period of six months", Glob Epidemi Obes, 1, pp.5~ (2013)
25. Moura LP, "Exercise and Spirulina control non-alcoholic hepatic steatosis and lipid profile in diabetic Wistar rats", Lipids Health Dis, 10, pp.77~ (2011)
26. Layam A, "Antidiabetic property of Spirulina", Diabetol Croat, 35, pp.29~33 (2007)
27. Hayashi O, "Enhancement of antibody production in mice by dietary Spirulina platensis", J Nutr Sci Vitaminol (Tokyo), 40, pp.431~441 (1994)
28. Watanuki H, "Immunostimulant effects of dietary Spirulina platensis on carp, Cyprinus carpio", Aquaculture, 258, pp.157~163 (2006)
29. Qureshi MA, "Spirulina platensis extract enhances chicken macrophages functions after in vitro exposure", J Nutr Immunol, 3, pp.35~45 (1996)
30. Hirahashi T, "Activation of the human innate immune system by Spirulina: augmentation of interferon production and NK cytotoxicity by oral administration of hot water extract of Spirulina platensis", Int Immunopharmacol, 2, pp.423~434 (2002)
31. Selmi C, "The effects of Spirulina on anemia and immune function in senior citizens", Cell Mol Immunol, 8, pp.248~254 (2011)
32. Park HJ, "A randomized double-blind, placebo-controlled study to establish the effects of Spirulina in elderly Koreans", Ann Nutr Metab, 52, pp.322~328 (2008)
33. Hyun-Sook Lee, "The influence of obesity on the effects of spirulina supplementation in the human metabolic response of Korean elderly", Nutrition Research and Practice, 10(4), pp.418~423 (2016), 한국영양학회
34. The Korean Nutrition Society, "CAN-Pro 4.0: nutritional assessment program", The Korean Nutrition Society, ~ (2010)
35. Friedewald WT, "Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge", Clin Chem, 18, pp.499~502 (1972)
36. Mosmann T., "Rapid colorimetric assay for cellular growth and survival:application to proliferation and cytotoxicity assays", J Immunol Methods, 65, pp.55~63 (1983)
37. Bielinski SJ, "Circulating MCP-1 levels shows linkage to chemokine receptor gene cluster on chromosome 3: the NHLBI family heart study follow-up examination", Genes Immun, 8, pp.684~690 (2007)
38. Deshmane SL, "Monocyte chemoattractant protein-1 (MCP-1): an overview", J Interferon Cytokine Res, 29, pp.313~326 (2009)
39. Yamamoto T, "Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop", J Immunol, 164, pp.6174~6179 (2000)
40. Xia M, "Recent developments in CCR2 antagonists", Expert Opin Ther Pat, 19, pp.295~303 (2009)
41. Rollins BJ, "Chemokines", Blood, 90, pp.909~928 (1997)
42. de Lemos JA, "Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes", Circulation, 107, pp.690~695 (2003)
43. Deo R, "Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis", J Am Coll Cardiol, 44, pp.1812~1818 (2004)
44. Navratilova Z., "Polymorphisms in CCL2&CCL5 chemokines", chemokine receptors genes and their association with diseases, 2006, pp.150, 191~204
45. Szalai C, "Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity", J Allergy Clin Immunol, 108, pp.375~381 (2001)
46. Arakelyan A, "Functional genetic polymorphisms of monocyte chemoattractant protein 1 and C-C chemokine receptor type 2 in ischemic stroke", J Interferon Cytokine Res, 34, pp.100~105 (2014)
47. Bjarnadottir K, "Examination of genetic effects of polymorphisms in the MCP-1 and CCR2 genes on MI in the Icelandic population", Atherosclerosis, 188, pp.341~346 (2006)
48. Angeles-Martínez J, "Monocyte chemoattractant protein-1 gene (MCP-1) polymorphisms are associated with risk of premature coronary artery disease in Mexican patients from the Genetics of Atherosclerotic Disease (GEA) study", Immunol Lett, 167, pp.125~130 (2015)
49. Xu J, "The MCP-1 gene A-2518G polymorphism confers an increased risk of vascular complications in type 2 diabetes mellitus patients", Genet Test Mol Biomarkers, 19, pp.411~417 (2015)
50. Hou S, "Monocyte chemoattractant protein-1 -2518 A", G single nucleotide polymorphism in Chinese Han patients with ocular Behçet's disease, 2010, pp.71, 79~82
51. Zuo S, "Association of monocyte chemoattractant protein-1-2518A", G polymorphism and risk of coronary artery disease among the Chinese population: a meta-analysis, 2015, pp.8, 15182~15189
52. Jemaa R, "Association between the -2518G", A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and myocardial infarction in Tunisian patients, 2008, pp.390, 122~125
53. Kaur R, "Association of -2518A>G promoter polymorphism in the monocyte chemoattractant protein-1(MCP-1) gene with type 2 diabetes and coronary artery disease", Genet Test Mol Biomarkers, 17, pp.750~755 (2013)
54. Okopień B, "Plasma cytokines as predictors of coronary heart disease", Res Commun Mol Pathol Pharmacol, 112, pp.5~15 (2002)
55. Gao HH, "Correlations of MCP-1 -2518A>G polymorphism and serum levels with cerebral infarction risk: a meta-analysis", DNA Cell Biol, 33, pp.522~530 (2014)
56. 박희정, "한국인의 MCP-1 유전자 다형성과 유전형에 따른 심혈관계질환 위험인자와의 연관성", Journal of Nutrition and Health, 46(6), pp.511~520 (2013), 한국영양학회[DOI]
57. Nelken NA, "Monocyte chemoattractant protein-1 in human atheromatous plaques", J Clin Invest, 88, pp.1121~1127 (1991)
58. Nikolich-Žugich J., "T cell aging: naive but not young", J Exp Med, 201, pp.837~840 (2005)
59. Halkes CJ, "Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: effects of expanded-dose simvastatin", Arterioscler Thromb Vasc Biol, 21, pp.1526~1530 (2001)
60. Muscari A, "Association of serum C3 levels with the risk of myocardial infarction", Am J Med, 98, pp.357~364 (1995)
61. Hoskinson CD, "Age-related changes in mitogeninduced lymphocyte proliferation and polymorphonuclear neutrophil function in the piglet", J Anim Sci, 68, pp.2471~2478 (1990)

관련 논문AI추천